Rheumatology CPT & HCPCS Families Coded
Clean Claim Rate
Years in U.S. Medical Billing
Rheumatology practices without strong biologic authorization and infusion coding controls commonly lose 10 to 20% of revenue to authorization delays, mismatched J-codes, and under-documented chronic disease E/M visits. Most of it traces back to a small number of recurring coding decisions, which is exactly where specialty-specific billing pays for itself.
Where rheumatology billing actually goes wrong
Rheumatology billing, done right
The coding decisions that cause most rheumatology denials, handled by billers who know the specialty, not just the CPT book.
Biologic Prior Authorization Tracking
Since most biologics require prior authorization, often with documented step therapy first, we track authorization status from the treatment-planning stage forward. As a result, treatment doesn't stall behind an unresolved approval.
Biologic & DMARD J-Code Precision
Because each biologic and DMARD bills under its own specific J-code with units matching the documented dose, we verify this alignment before every infusion or injection claim goes out.
Infusion Administration Hierarchy
Since infusion administration follows a strict hierarchy for initial, sequential, and additional services, we sequence every infusion visit to match what the documentation actually supports.
Complex Chronic Disease E/M Coding
Rheumatology visits often involve multiple medications, lab monitoring, and ongoing disease activity assessment. Therefore, we code E/M levels to reflect this genuine complexity rather than defaulting to a flat visit level.
Joint Injection & Aspiration Coding
Joint injections and aspirations use codes that depend on joint size and number of joints treated. Consequently, we code these procedures based on exactly what the documentation supports.
Modifier 25 for Same-Day Infusion Visits
When a rheumatologist evaluates a patient and administers an infusion the same day, modifier 25 needs clear supporting documentation. However, we apply it only when the note genuinely supports two separately identifiable services.
Rheumatology Billing Services
Everything your rheumatology practice's billing needs, in one place
Full-service rheumatology RCM — charge entry, claims submission, payment posting, denial management.
Prior authorization tracking for biologics and DMARDs, including step-therapy documentation.
Infusion coding mapped to the correct administration hierarchy.
J-code billing for biologics and DMARDs with dosage-unit verification.
E/M coding for complex, chronic disease management visits.
Joint injection and aspiration coding by joint size and count.
Drug wastage documentation with modifier JW billing.
Modifier 25 documentation review for same-day infusion visits.
Lab monitoring coordination for biologic and DMARD therapy.
Credentialing and payer enrollment for rheumatologists and APPs.
Eligibility verification and coordination of benefits.
Aging A/R cleanup and legacy claims recovery.
Rheumatology-specific, not generalist
Billers who know cath lab bundling rules
A biller who treats every specialty the same way will schedule a biologic infusion without confirming prior authorization, and then never understand why the claim denied. Since rheumatology revenue leaks rarely sit in one place, they instead spread across authorization tracking, J-code precision, and complex E/M documentation that most billers never learn to manage together. Ultimately, treating rheumatology like standard internal medicine billing is exactly where the revenue disappears.
Talk to a specialistCaught before submission
Fewer denials, faster reimbursement
Rheumatology practices without strong front-end controls commonly see first-pass denial rates of 12 to 20%, driven largely by biologic authorization delays, J-code dosage mismatches, and under-documented chronic disease E/M visits. Because we catch these before the claim goes out rather than after the denial comes back, practices see cleaner claims from the first submission.
See how it works
What we hold ourselves to
Our values, in practice
Intake & Systems Review
We audit current prior authorization and infusion coding practices.
Charge Capture & Coding
Encounters get coded with correct J-codes, infusion hierarchy, and E/M complexity level.
Claims Scrubbing
Claims run through payer-specific edits before submission.
Submission & Tracking
Clean claims go out daily, and every claim gets tracked to resolution.
Denial Management
Denials get corrected and resubmitted within payer timely-filing windows.
Authorization Monitoring
Biologic and DMARD authorizations get tracked from request through approval and renewal.
Reporting
Monthly reports show clean claim rate, denial trends, and days in A/R by drug and service category.
Questions, answered
Rheumatology billing, answered
What rheumatology practices ask most before switching billing partners.
What makes rheumatology billing different from other internal medicine subspecialties?
Rheumatology billing centers heavily on biologic and DMARD therapy, which requires precise J-code billing, infusion administration coding, and one of the heaviest prior authorization burdens in medicine. Because chronic autoimmune disease management also demands complex E/M documentation, rheumatology combines drug-billing precision with chronic care coding in a way most subspecialties don't.
Why do biologic infusion claims get denied so often?
Most biologics require prior authorization before treatment, often preceded by documented step therapy showing conventional treatments failed first. When authorization isn't confirmed before the infusion happens, or when the J-code doesn't match the documented dose exactly, the claim denies.
What is step therapy, and how does it affect rheumatology billing?
Step therapy requires documented evidence that a patient tried and failed conventional treatments before a payer approves a more expensive biologic therapy. Since this documentation directly supports the prior authorization request, missing or incomplete step-therapy records can delay or block approval for the more advanced treatment.
How does joint injection billing work in rheumatology?
Joint injection and aspiration codes depend on the size of the joint treated and how many joints were injected during the visit. Coding based on joint size and count accurately, rather than defaulting to one code regardless of the procedure performed, prevents denials and ensures correct reimbursement.
Why does E/M coding matter so much for chronic rheumatology visits?
Rheumatology visits often involve managing multiple medications, reviewing lab monitoring results, and assessing ongoing disease activity, all of which support a higher level of medical decision-making complexity. When providers default to a conservative E/M level regardless of this complexity, the documented care doesn't translate into correct reimbursement.
What denial rate should a rheumatology practice expect?
A well-run rheumatology billing operation should see a denial rate under 7%, with first-pass clean claims above 93%. Practices without strong prior authorization and J-code controls commonly see denial rates well above that, since biologic-related issues drive a large share of preventable rheumatology denials.
Find out how much revenue
your practice is leaving on the table.
Get a free, no-obligation revenue audit. We'll analyze your billing and show you the exact dollars you could be collecting.
No contracts to review. No pressure. Just numbers.